These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 11488623)
21. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin. Brown KJ; Hendry IA; Parish CR J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903 [TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics insights into protein-glycosaminoglycan systems from microsecond-scale simulations. Bojarski KK; Sieradzan AK; Samsonov SA Biopolymers; 2019 Jul; 110(7):e23252. PubMed ID: 30667535 [TBL] [Abstract][Full Text] [Related]
23. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. DiGabriele AD; Lax I; Chen DI; Svahn CM; Jaye M; Schlessinger J; Hendrickson WA Nature; 1998 Jun; 393(6687):812-7. PubMed ID: 9655399 [TBL] [Abstract][Full Text] [Related]
24. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857 [TBL] [Abstract][Full Text] [Related]
25. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Noti C; de Paz JL; Polito L; Seeberger PH Chemistry; 2006 Nov; 12(34):8664-86. PubMed ID: 17066397 [TBL] [Abstract][Full Text] [Related]
27. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446 [TBL] [Abstract][Full Text] [Related]
28. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499 [TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor. LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256 [TBL] [Abstract][Full Text] [Related]
30. Microarrays of synthetic heparin oligosaccharides. de Paz JL; Noti C; Seeberger PH J Am Chem Soc; 2006 Mar; 128(9):2766-7. PubMed ID: 16506732 [TBL] [Abstract][Full Text] [Related]
31. Effects of solute multivalence on the evaluation of binding constants by biosensor technology: studies with concanavalin A and interleukin-6 as partitioning proteins. Kalinin NL; Ward LD; Winzor DJ Anal Biochem; 1995 Jul; 228(2):238-44. PubMed ID: 8572301 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988 [TBL] [Abstract][Full Text] [Related]
33. Differential scanning fluorimetry measurement of protein stability changes upon binding to glycosaminoglycans: a screening test for binding specificity. Uniewicz KA; Ori A; Xu R; Ahmed Y; Wilkinson MC; Fernig DG; Yates EA Anal Chem; 2010 May; 82(9):3796-802. PubMed ID: 20353159 [TBL] [Abstract][Full Text] [Related]
34. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536 [TBL] [Abstract][Full Text] [Related]
35. Portable evanescent wave fiber biosensor for highly sensitive detection of Shigella. Xiao R; Rong Z; Long F; Liu Q Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():1-5. PubMed ID: 24836193 [TBL] [Abstract][Full Text] [Related]
36. A generic strategy for co-presentation of heparin-binding growth factors based on CVD polymerization. Deng X; Lahann J Macromol Rapid Commun; 2012 Sep; 33(17):1459-65. PubMed ID: 22887691 [TBL] [Abstract][Full Text] [Related]
37. Accelerated tissue integration into porous materials by immobilizing basic fibroblast growth factor using a biologically safe three-step reaction. Kakinoki S; Sakai Y; Fujisato T; Yamaoka T J Biomed Mater Res A; 2015 Dec; 103(12):3790-7. PubMed ID: 26034014 [TBL] [Abstract][Full Text] [Related]
38. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin. Strain AJ; McGuinness G; Rubin JS; Aaronson SA Exp Cell Res; 1994 Feb; 210(2):253-9. PubMed ID: 7507851 [TBL] [Abstract][Full Text] [Related]
39. Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition. Simonis D; Fritzsche J; Alban S; Bendas G Biochemistry; 2007 May; 46(20):6156-64. PubMed ID: 17458940 [TBL] [Abstract][Full Text] [Related]